Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Jia-Yin XuGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Hui-Hua DongGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Li-Juan LiaoGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Shi-Xian YangAffiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Lu-Yao WangGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.
Hao ChenDepartment of Pathology, School of Basic Medical Sciences, Wannan Medical College, Wuhu, China.
Peipei LuoDepartment of Gastroenterology, Wujin People's Hospital affiliated to JiangSu University, Changzhou, China.
Liang HuangGuangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise, China.ORCID 0000-0001-7937-8150
Ai-Xing GuanAffiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.ORCID 0009-0007-7409-941X
Yan-Qiang HuangAffiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.ORCID 0000-0002-0867-0178
Funding
MOST | National Natural Science Foundation of China (NSFC) 32060018
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Deoxyshikonin: a promising lead drug grass against drug resistance or sensitivity to · full record | OpenQuestion